Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen CorporationfiledCriticalNeurogen Corporation
Priority to YU35292ApriorityCriticalpatent/YU35292A/sh
Publication of YU35292ApublicationCriticalpatent/YU35292A/sh
IZVESNI IMIDAZOHINOKSALINI NOVA KLASA GABA MOŽDANIH RECEPTORSKIH LIGANADA, ovaj pronalazak obuhvata jedinjenja formule: i farmaceutski prihvatljive njihove netoksične soli, gde R1, R2, R3, R4, X I W su promenljivi. Ova jedinjenja su visoko selektivni agonisti, antagonisti ili inverzni agonisti za GABAs moždane receptore ili njihove prolekove i korisna su u dijagnozi i tretiranju poremećaja sna, nesanice uznemirenosti, predoziranja sa benzodiazepinskim lekovima i pojačanju memorije.
YU35292A1992-04-031992-04-03Izvesni imidazohinoksalini nova klasa gaba moždanih receptorskih liganada
YU35292A
(sh)